Occupy Corporatism
by Susanne Posel
Researchers for the Cochrane Collaboration have discovered that Tamiflu has no effect in preventing children from succumbing to influenza.
In adults, Tamiflu was shown to reduce symptoms of influenza; however “no proof people taking Tamiflu were less likely to be hospitalized or suffer serious flu complications.”
The Cochrane researchers issued a “joint call to government and health policy decision makers the world over asking, in light of the latest findings from the Cochrane Review, would you make the same recommendations today, choosing to stockpile Tamiflu?”
Tamiflu was found to cause a rise in risk of psychiatric disorders as well as kidney complications.
The findings of the study showed that Tamiflu and Relenza were “unproven against preventing pandemics and may cause more harm in some patients than good.”
Researchers found that Roche and GlaxoSmithKline provided incomplete data as evidence for their submitted drug studies.
In Singapore, the Ministry of Health (MOH) has said they will consider the effectiveness of Tamiflu and Relenza which is stockpiled by governments to use in case of a pandemic due to the findings of a recent study.
The MOH stated : “At the beginning of an influenza pandemic, these drugs are the only specific form of treatment for influenza. Pandemic vaccines to prevent infection will usually only be available four to six months after the pandemic begins, following which the need for antiviral treatment would diminish.”
The MOH states that they had in fact “built up a national stockpile of antiviral drugs, including Tamiflu and Relenza, which forms part of Singapore’s national preparedness against influenza pandemics.”
Back in 2005, the British government spent £424 million on Tamiflu stockpiles because “scientists warned that as many as 700,000 Britons could die from deadly bird flu. “
The US government spent more than $1.3 billion buying a strategic reserve of antivirals
Shockingly, the Cochrane researchers stated that in “2009, a lack of access to available trial data hampered the efforts of the Cochrane researchers to verify the safety and effectiveness of Tamiflu – and led to questions over decisions to stockpile the drug while the risks and benefits remained uncertain.”
A study released in April 2012 by Peter Doshi who was funded by the Agency for Healthcare Research and Quality, displayed a new level of corruption that shows the FDA as knowingly approving drugs that serve no medical purpose.
These drugs, in most cases, had horrific and harmful effects.
Named in this study was the drug, Tamiflu (oseltamivir). This is the same drug that was endorsed as the cure all for the swine flu epidemic.
One report explained: “The latest study includes a review of the influenza antiviral drug Tamiflu (oseltamivir), which was pushed on the world during the 2009 pandemic and heralded as THE intervention for the so-called deadly swine flu. What researchers found in retrospect is that much information that regulators should have known about the efficacy and safety of this drug was either hidden or ignored.”
Researchers of the study stated: “This analysis, conducted by Kaiser and colleagues, proposed that oseltamivir treatment of influenza reduced both secondary complications and hospital admission. In contrast, the Food and Drug Administration (FDA), which approved Tamiflu in 1999 and was aware of these same clinical trials, concluded that Tamiflu had not been shown to reduce complications, and required an explicit statement in the drug’s label to that effect.”
ConspiracyAnalyst.org 